MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinsonism"

  • MDS Virtual Congress 2020

    Chromogranin B in cerebrospinal fluid as a novel biomarker for Progressive supranuclear palsy

    H. Takigawa, R. Sakata, T. Inoue-Nishida, H. Kowa, K. Namashima, R. Hanajima (Yonago, Japan)

    Objective: To identify the biomarker associated with progressive supranuclear palsy (PSP) for better understanding of a pathophysiology and clinical diagnosis. Background: PSP is one of…
  • MDS Virtual Congress 2020

    Socio-economic determinants of diagnostic latency in Parkinson’s disease patients

    P. Surathi, E. Feinstein (Newark, NJ, USA)

    Objective: Early diagnosis is important in optimal management of patients with Parkinson’s disease (PD). There are several factors which can contribute to delay in diagnosis,…
  • MDS Virtual Congress 2020

    The Feasibility of Using of the Non-Medication in the Treatment of Post-Stroke Vascular Parkinsonism

    O. Tondiy, O. Zavalna (Kharkiv, Ukraine)

    Objective: Vascular parkinsonism is an infrequent but unpleasant complication of cerebrovascular disease, in particular brain stroke. Background: The effect of the complex treatment with non-medication…
  • MDS Virtual Congress 2020

    What Matters Most to Individuals with Parkinson’s Disease: Results from Qualitative Interviews

    A. Arky, C. Zizzi, E.R Dorsey, C. Heatwole (Rochester, NY, USA)

    Objective: To use interviews from individuals with Parkinson's disease (PD) to better understand the symptomology of the disease. Background: It is important to understand the…
  • MDS Virtual Congress 2020

    Quantitative extremity movement measurement

    J. Brasic, T. Harrigan, B. Hwang, K. Mills, A. Pantelyat, J. Bang, A. Syed, P. Vyas, S. Martin, A. Jamal, R. Panaparambil, A. Gaite, L. Ziegelman, M. Hernandez (Baltimore, MD, USA)

    Objective: To demonstrate the feasibility of a simple low-cost procedure to quantitatively measure movements in the extremities of people with Parkinson's disease and other movement…
  • MDS Virtual Congress 2020

    Directional versus conventional subthalamic deep brain stimulation for advanced Parkinson’s disease: Short-term outcomes of a pilot study

    A. Gamaleya, A. Poddubskaya, S. Omarova, A. Tomskiy (Moscow, Russian Federation)

    Objective: To investigate efficacy of STN-DBS via segmented directional leads compared to conventional omnidirectional leads in PD-patients. Background: Recently, novel leads which allow stimulation steering in…
  • MDS Virtual Congress 2020

    Uptake in Directional Stimulation and Primary Cell Longevity in Deep Brain Stimulation of Globus Pallidus Pars Interna for Parkinson’s Disease

    C. Wu, C. Matias, S. Pallavaram, A. Sharan, T. Liang (Philadelphia, PA, USA)

    Objective: To retrospectively assess the use of directional programming in deep brain stimulation of globus pallidus pars interna (GPi-DBS) in patients with Parkinson’s disease (PD).…
  • MDS Virtual Congress 2020

    Slow Motion Analysis of Repetitive Tapping (SMART) test: a new means to assess bradykinesia

    C. Simonet, C. Lambert, R. Rees, M. Galmes, A. Schrag, A. Noyce (London, United Kingdom)

    Objective: To develop a quantitative and objective tool to track repetitive tapping movement (RTM) using a slow motion capture and compare patients with Parkinson’s disease…
  • MDS Virtual Congress 2020

    Mechanisms of chronic neuroleptic-induced parkinsonism examined with positron emission tomography

    M. Galoppin, P. Berroir, J. Soucy, E. Stip, P. Blanchet (Montreal, QC, Canada)

    Objective: To investigate the cause of chronic neuroleptic drug-induced parkinsonism (NIP) through examination of the profile of striatal monoaminergic nerve terminal density using positron emission…
  • MDS Virtual Congress 2020

    Initial Results from the Zambian Epidemiology of Parkinson’s disease and Healthcare Registry (ZEPHyR)

    T. Lee, O. Siddiqi, M. Atadzhanov, D. Saylor, J. Fleisher (Aurora, CO, USA)

    Objective: To describe the launch and preliminary findings of ZEPHyR, the first Parkinson’s Disease (PD) registry in Zambia. Background: PD is the second most common…
  • « Previous Page
  • 1
  • …
  • 91
  • 92
  • 93
  • 94
  • 95
  • …
  • 388
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Effect of Ketone Ester Supplementation on Motor and Non-Motor symptoms in Parkinson's Disease
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • An atypical and interesting feature of Parkinson´s disease
  • “Striatal Hand Signs” and early diagnosis of Parkinson's Disease: The “Monkey-Wrench Sign”.
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • Effect of Ketone Ester Supplementation on Motor and Non-Motor symptoms in Parkinson's Disease
  • An atypical and interesting feature of Parkinson´s disease
  • Yerba Mate (Ilex paraguaiensis) protects dopaminergic neurons degeneration and improve their maturation in culture
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley